% | $
Quotes you view appear here for quick access.

MultiCell Technologies, Inc. Message Board

  • sfsi_mont sfsi_mont Jul 2, 2013 12:03 PM Flag

    . .there is no MCT-275 .. people watch out

    watch out for the fake posts in here.
    I don't know what this person's intentions are . . yet
    that posted a comment about MCT-275. There is no such study called mct-275.
    This person doesn't know what he is talking about..

    MultiCell Technologies is working on treatments for Cancer, Cancer tumors and Multiple Sclerosis fatigue.
    Their current pipeline consists of:

    MCT-125 , a Phase 2 therapeutic candidate for the treatment of PMSF which has demonstrated efficacy in a 138-patient Phase IIa clinical trial.

    MCT-465 , a preclinical synthetic dsRNA therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers such as those expressing TLR-3.

    MCT-475 , a discovery stage antibody therapeutic candidate used in combination with dsRNA for the treatment of solid tumor cancers; and

    MCT-485 , a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of certain cancers.

    All this is stated within their most recent 10-K published on 2/28/2013,
    and their website.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.0003-0.0001(-25.00%)Oct 6 3:56 PMEDT